ScienceDaily
Your source for the latest research news
Follow Facebook Twitter LinkedIn Subscribe RSS Feeds Newsletters
New:
  • Black Death Shaped Evolution of Immunity Genes
  • Methane-Eating 'Borgs' Taking Earth's Microbes
  • Pain Relief Without Side Effects and Addiction
  • Accounting For Dark Energy and Dark Matter
  • Meet the First Neanderthal Family
  • Physicists Confirm Hitch in Proton Structure
  • Five Hours' Sleep a Night: Disease Risk
  • Energetics of Piercing Fangs and Claws
  • Hair Straightening Chemicals and Uterine Cancer
  • Ostriches With Similar Interests Form Groups
advertisement
Follow all of ScienceDaily's latest research news and top science headlines!
Science News
from research organizations

1

2

Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient

Date:
November 30, 2017
Source:
European Society for Medical Oncology
Summary:
The first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans has now been revealed by researchers. They report that while treating an HIV-infected lung cancer patient with the cancer drug nivolumab, they observed a 'drastic and persistent decrease' in the reservoirs of cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by antiretroviral therapy.
Share:
FULL STORY

Doctors in France have found the first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans.

advertisement

In a letter published in the cancer journal Annals of Oncology, researchers led by Professor Jean-Philippe Spano, head of the medical oncology department at Pitie-Salpetriere Hospital AP-HP in Paris, France, report that while treating an HIV-infected lung cancer patient with the cancer drug nivolumab, they observed a "drastic and persistent decrease" in the reservoirs of cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by anti-retroviral therapy.

These reservoirs of HIV-infected cells are found in the immune system in organs such as the brain, bone marrow and genital tract. They lie dormant and cannot be eliminated by anti-retroviral therapy, nor by the weakened immune system, so that if treatment is stopped at any time, the virus starts to replicate and infect more cells again, while the immune system cannot suppress this rebound of HIV infection. If scientists could find a way of clearing away the reservoirs of HIV-infected cells, then it might enable them to eradicate the virus completely, making it possible to cure HIV patients.

HIV primarily infects CD4 T cells, which are a type of white blood cell that plays an important role in regulating the immune response. When under attack from HIV they not only become infected but also exhausted, meaning they are less able to fight the infection.

Professor Spano explained: "Dormant CD4 T cells infected with HIV are not actively producing HIV: they are latently infected. Latent HIV reservoirs are established during the earliest stage of HIV infection and throughout the course of the disease. When a latently infected cell is reactivated, the cell begins to produce HIV again. However, this re-activation is blocked in most latently-infected cells by cellular molecules called immune check-points. One of these check-points is programmed death-1 (PD-1), which also blocks the functions of CD4 T cells in fighting the virus.

"Increasingly, researchers have been looking into the use of certain drugs that appear to re-activate the latent HIV-infected cells. This could have the effect of making them visible to the immune system, which could then attack them. Drugs that inhibit immune check-points such as PD-1 are well known in the cancer field as being very efficient at restoring immune defences by removing the brake, enabling the immune cells to spring into action to reject the cancer cells. It was thought, but until now not demonstrated, that inhibitors of immune check-points could, in a similar way, wake up dormant HIV-infected cells and also the immune defences against the virus."

Nivolumab is PD-1 inhibitor, which is used to treat several cancers in their advanced stages, including melanoma, non-small cell lung cancer and kidney cancer. The researchers used it to treat an HIV-infected patient with non-small cell lung cancer after he relapsed following surgery and chemotherapy for his tumour. So far, the 51-year-old man has received 31 injections of nivolumab every 14 days since December 2016. He was diagnosed as HIV-positive in 1995 and the cancer was diagnosed in May 2015.

advertisement

When the researchers first gave nivolumab to the patient, HIV was undetectable in blood samples. It then increased progressively up to day 45 before decreasing again. At the same time T cell activity increased, with a marked increase in the activity of another T cell, CD8, from day 30 to 120. By day 120 the reservoirs of HIV-infected cells "showed a drastic and persistent decrease," report the researchers in their letter to Annals of Oncology.

Professor Spano said: "In this patient we observed, as expected, both a re-activation of HIV and an increase in CD8 T cell responses against HIV, which resulted in the drastic decrease in the HIV reservoir, thus leading to a sustained reduction of the HIV reservoirs.

"This is the first demonstration of this mechanism working in humans. It could have implications for HIV patients, both with and without cancer, as it can work on HIV reservoirs and tumour cells independently. The absence of side effects in this patient is also good news, and suggests this could be an optimum treatment for HIV-infected patients with cancer."

However, the researchers are also cautious about their results. Professor Spano continued: "Firstly, this is the first case of such a drastic decrease of the HIV reservoir, and we must remain careful, especially because this is only one case; we have published details of another case where there was no decrease of the HIV reservoir.

"Secondly, we have to evaluate -- in clinical trials and in a group of 50 French patients we are treating currently -- the potential toxicities of these drugs in HIV infected people. And finally, we have to identify markers that can predict HIV response to the anti-PD-1 therapy so that treatment can be personalised, especially as we observed one responder and one non-responder."

Editor-in-chief of Annals of Oncology, Fabrice André, Professor in the Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France, commented: "Although this is a single case study, it is an exciting result. Anti-HIV drugs usually stop virus replication but don't cure the patients who still have reservoirs of the virus. This study generates the hypothesis that drugs that make the virus disappear could, perhaps, cure patients."

The patient will be treated with more nivolumab later this month and his cancer will also be assessed then. "For the moment, he is doing quite well and doesn't show any signs of disease, even though the cancer is progressing slowly, which suggests it is not optimally controlled," said Professor Spano.

make a difference: sponsored opportunity

Story Source:

Materials provided by European Society for Medical Oncology. Note: Content may be edited for style and length.


Journal Reference:

  1. A Guihot, A -G Marcelin, M -A Massiani, A Samri, C Soulié, B Autran, J -P Spano. Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer. Annals of Oncology, 2017; DOI: 10.1093/annonc/mdx696

Cite This Page:

  • MLA
  • APA
  • Chicago
European Society for Medical Oncology. "Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient." ScienceDaily. ScienceDaily, 30 November 2017. <www.sciencedaily.com/releases/2017/11/171130214929.htm>.
European Society for Medical Oncology. (2017, November 30). Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient. ScienceDaily. Retrieved October 20, 2022 from www.sciencedaily.com/releases/2017/11/171130214929.htm
European Society for Medical Oncology. "Cancer drug leads to 'drastic decrease' in HIV infection in lung cancer patient." ScienceDaily. www.sciencedaily.com/releases/2017/11/171130214929.htm (accessed October 20, 2022).

  • RELATED TOPICS
    • Health & Medicine
      • HIV and AIDS
      • Infectious Diseases
      • Lung Cancer
      • Immune System
      • Lymphoma
      • Diseases and Conditions
      • STD
      • Cancer
advertisement

  • RELATED TERMS
    • HIV test
    • Antiretroviral drug
    • HIV
    • AIDS
    • Prostate cancer
    • Gene therapy
    • Cervical cancer
    • Metastasis
advertisement

  Print   Email   Share

advertisement

1

2

3

4

5
Most Popular
this week

HEALTH & MEDICINE
Eating Late Increases Hunger, Decreases Calories Burned, and Changes Fat Tissue
Clusters of Genes Help Mice Live Longer
Study of Over 5 Million People's DNA Reveals Genetic Links to Height
MIND & BRAIN
Dogs Can Smell When We're Stressed, Study Suggests
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Healthy Aging Requires an Understanding of Personality Types
LIVING & WELL
Did the Pandemic Change Our Personalities?
Watching TV With Your Child Can Help Their Cognitive Development, Study Suggests
Coffee Drinking Is Associated With Increased Longevity
advertisement

Strange & Offbeat
 

HEALTH & MEDICINE
RNA Origami Enables Applications in Synthetic Biology
Unlocking the Power of Our Emotional Memory
Robotic Drug Capsule Can Deliver Drugs to Gut
MIND & BRAIN
Our Brains Use Quantum Computation
Human Brain Cells in a Dish Learn to Play Pong in Real Time
Dogs Can Smell When We're Stressed, Study Suggests
LIVING & WELL
Researchers Develop Painless Tattoos That Can Be Self-Administered
Washing Dishes With Superheated Steam More Effective, Earth-Friendly
News Addiction Linked to Not Only Poor Mental Wellbeing but Physical Health Too, New Study Shows
Explore More
from ScienceDaily

RELATED STORIES

New Study Reveals Why HIV Remains in Human Tissue Even After Antiretroviral Therapy
Mar. 25, 2022 — Thanks to antiretroviral therapy, HIV infection is no longer the life sentence it once was. But despite the effectiveness of drugs to manage and treat the virus, it can never be fully eliminated from ...
Human Immune Cells Have Natural Alarm System Against HIV
Feb. 4, 2021 — Researchers have identified a potential way to eradicate the latent HIV infection that lies dormant inside infected immune cells. Studying human immune cells, the researchers showed that such cells ...
AIDS: An Approach for Targeting HIV Reservoirs
Dec. 20, 2018 — Current HIV treatments need to be taken for life by those infected as antiretroviral therapy is unable to eliminate viral reservoirs lurking in immune cells. Scientists have identified the ...
HIV in Liver Cells Found to Be Inactive, Narrowing Potential Treatment Targets
Nov. 29, 2018 — In a proof-of-principle study, researchers revealed that certain immune system cells found in the human liver, called liver macrophages, contain only inert HIV and aren't likely to reproduce ...
advertisement


SD
  • SD
    • Home Page
    • Top Science News
    • Latest News
  • Home
    • Home Page
    • Top Science News
    • Latest News
  • Health
    • View all the latest top news in the health sciences,
      or browse the topics below:
      Health & Medicine
      • Allergy
      • Alternative Medicine
      • Birth Control
      • Cancer
      • Diabetes
      • Diseases
      • Heart Disease
      • HIV and AIDS
      • Obesity
      • Stem Cells
      • ... more topics
      Mind & Brain
      • ADD and ADHD
      • Addiction
      • Alzheimer's
      • Autism
      • Depression
      • Headaches
      • Intelligence
      • Psychology
      • Relationships
      • Schizophrenia
      • ... more topics
      Living Well
      • Parenting
      • Pregnancy
      • Sexual Health
      • Skin Care
      • Men's Health
      • Women's Health
      • Nutrition
      • Diet and Weight Loss
      • Fitness
      • Healthy Aging
      • ... more topics
  • Tech
    • View all the latest top news in the physical sciences & technology,
      or browse the topics below:
      Matter & Energy
      • Aviation
      • Chemistry
      • Electronics
      • Fossil Fuels
      • Nanotechnology
      • Physics
      • Quantum Physics
      • Solar Energy
      • Technology
      • Wind Energy
      • ... more topics
      Space & Time
      • Astronomy
      • Black Holes
      • Dark Matter
      • Extrasolar Planets
      • Mars
      • Moon
      • Solar System
      • Space Telescopes
      • Stars
      • Sun
      • ... more topics
      Computers & Math
      • Artificial Intelligence
      • Communications
      • Computer Science
      • Hacking
      • Mathematics
      • Quantum Computers
      • Robotics
      • Software
      • Video Games
      • Virtual Reality
      • ... more topics
  • Enviro
    • View all the latest top news in the environmental sciences,
      or browse the topics below:
      Plants & Animals
      • Agriculture and Food
      • Animals
      • Biology
      • Biotechnology
      • Endangered Animals
      • Extinction
      • Genetically Modified
      • Microbes and More
      • New Species
      • Zoology
      • ... more topics
      Earth & Climate
      • Climate
      • Earthquakes
      • Environment
      • Geography
      • Geology
      • Global Warming
      • Hurricanes
      • Ozone Holes
      • Pollution
      • Weather
      • ... more topics
      Fossils & Ruins
      • Ancient Civilizations
      • Anthropology
      • Archaeology
      • Dinosaurs
      • Early Humans
      • Early Mammals
      • Evolution
      • Lost Treasures
      • Origin of Life
      • Paleontology
      • ... more topics
  • Society
    • View all the latest top news in the social sciences & education,
      or browse the topics below:
      Science & Society
      • Arts & Culture
      • Consumerism
      • Economics
      • Political Science
      • Privacy Issues
      • Public Health
      • Racial Disparity
      • Religion
      • Sports
      • World Development
      • ... more topics
      Business & Industry
      • Biotechnology & Bioengineering
      • Computers & Internet
      • Energy & Resources
      • Engineering
      • Medical Technology
      • Pharmaceuticals
      • Transportation
      • ... more topics
      Education & Learning
      • Animal Learning & Intelligence
      • Creativity
      • Educational Psychology
      • Educational Technology
      • Infant & Preschool Learning
      • Learning Disorders
      • STEM Education
      • ... more topics
  • Quirky
    • Top News
    • Human Quirks
    • Odd Creatures
    • Bizarre Things
    • Weird World
Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

  • Email Newsletters
  • RSS Feeds
Follow Us

Keep up to date with the latest news from ScienceDaily via social networks:

  • Facebook
  • Twitter
  • LinkedIn
Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

  • Leave Feedback
  • Contact Us
About This Site  |  Staff  |  Reviews  |  Contribute  |  Advertise  |  Privacy Policy  |  Editorial Policy  |  Terms of Use
Copyright 1995-2022 ScienceDaily or by other parties, where indicated. All rights controlled by their respective owners.
Content on this website is for information only. It is not intended to provide medical or other professional advice.
Views expressed here do not necessarily reflect those of ScienceDaily, its staff, its contributors, or its partners.
Financial support for ScienceDaily comes from advertisements and referral programs, where indicated.
— CCPA: Do Not Sell My Information — GDPR: Privacy Settings —